LA BioMed is an independent nonprofit research institute with more than 130 translationally focused researchers who are identifying and solving problems they experience first-hand in clinics at the Harbor-UCLA Medical Center. We have over 600 issued and pending patents and our innovations have led to ten start-up companies in the past five years. LA BioMed technologies have helped to generate numerous global medical breakthroughs including: invention of the modern cholesterol test, conception and development of the paramedic model of emergency patient care, first isolation and administration of a lung surfactant to treat premature babies, the FDA-approved drug Aldurazyme® for Mucopolysaccharidosis (aldurazyme.com), development of a low-cost antiseptic eye drop that prevents blindness in newborns and an FDA-approved drug to treat submental fullness (mykybella.com). We are actively seeking to build on our history of successful collaborations with companies both large and small. LA BioMed has dozens of technologies available for partnering across therapeutic, medical device, software, and diagnostic tool spaces.
